Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?

No pharmaceutical products have been demonstrated to be safe and effective to specifically treat coronavirus disease 2019 (COVID-19); therefore, the therapy administered to infected patients remains symptomatic and empiric. Alongside the development of new, often high-cost drugs, a different tactic...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassileva, Snejina, Mateeva, Valeria, Drenovska, Kossara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959882/
https://www.ncbi.nlm.nih.gov/pubmed/34518001
http://dx.doi.org/10.1016/j.clindermatol.2021.01.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959882/
https://www.ncbi.nlm.nih.gov/pubmed/34518001
http://dx.doi.org/10.1016/j.clindermatol.2021.01.020

Ejemplares similares